Company: BDRX
Filing Date: 2025-12-11
Form Type: F-1/A
Source: 0001214659-25-017944
Chunk: 162

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-12-11
Form: F-1/A
Chunk 162
---
 Policy (incorporated by reference to Exhibit 97.1 to the Company’s Annual Report on Form 20-F for the year ended December 31, 2023, filed with the SEC on April 19, 2024).                                                                                                      |
| 107^   |     | Filing Fee Table.                                                                                                                                                                                                                                                                        |

__

*Filed herewith.

| ^ | Previously filed.                                        |
| 

# | Management contract or compensatory plan or arrangement. |
| † | Certain portions of this exhibit (indicated by asterisks) have been omitted because they are not material 
 and would likely cause competitive harm to Biodexa Pharmaceuticals PLC if publicly disclosed.             |

<div align='center'>II-9</div>